Manufacturing and Production

Showing 15 posts of 5857 posts found.

shutter

UK universities join forces for early-stage COVID-19 therapy testing platform

July 7, 2020 Manufacturing and Production, Research and Development COVID-19, UK, coronavirus

A coalition of UK universities have come together to build a new clinical trial and drug testing platform to evaluate …
who_flag

Scientists urge World Health Organization to reconsider stance on COVID-19 airborne spread

July 7, 2020 Manufacturing and Production COVID-19, WHO, coronavirusm

239 scientists from over 30 countries are urging the World Health Organization to put more focus on assessing the possible …
china-pharmaceutical-industry

Emergent forges five-year partnership to produce one billion doses of Janssen’s COVID-19 vaccine

July 7, 2020 Manufacturing and Production COVID-19, Emergent, J&J, JJ, Janssen, coronavirus

As many pharma firms move to secure upscaled manufacturing capacity for their potential COVID-19 vaccines, Johnson & Johnson’s Janssen has …
johnsonsss

Johnson & Johnson cuts price of anti-TB medicine in poorer countries

July 7, 2020 Manufacturing and Production J&J, JJ, TB

Johnson & Johnson have announced that it will cut the price of its tuberculosis drug Bedaquiline, sold under the brand …
purdue

Jonathan Sackler, co-owner of Purdue Pharma, dies from cancer

July 7, 2020 Manufacturing and Production Purdue, opioid, opioid crisis

Jonathan Sackler, son of Purdue Pharma founder Raymond Sackler, died on 30 June from cancer, according to the company. He …
3018710552_f8cebf1dab_c

Tesla to offer “microfactories” to scale up production of CureVac’s potential COVID-19 vaccine

July 6, 2020 Manufacturing and Production, Sales and Marketing COVID-19, CureVac, Vaccine, tesla

Electric car firm Tesla has announced it will be supplying mobile molecular printer capacity to German firm CureVac, and possibly …
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

July 3, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronaviurs, top 10

Gilead features prominently in the news this week, as the US bought most of the world’s stock of the company’s …
vaccinessssssssssssssssssss

India to go ahead with human trials of COVID-19 vaccine in July

June 30, 2020 Manufacturing and Production COVID-19, Vaccine, coronavirus

A trial of a new Indian made vaccine will begin testing in humans from July. The vaccine is called Covaxin …
roche

Roche’s Phesgo combo secures US approval for metastatic HER2-positive breast cancer

June 30, 2020 Manufacturing and Production, Sales and Marketing FDA, Phesgo, Roche, US, breast cancer

The FDA has awarded marketing authorisation in the US to Roche’s Phesgo, a combination of subcutaneously injected Herceptin (trastuzumab) with …

New swine flu with pandemic potential identified in China

June 30, 2020 Manufacturing and Production flu, flu pandemic, swine flu

A new strain of flu has emerged in pigs in China, with scientists warning it has pandemic potential. Researchers call …
remsss

Gilead facing criticism for charging $2,340 for remdesivir

June 30, 2020 Manufacturing and Production COVID-19, coronavirus

Gilead has announced that it will charge $2,340 for a 5 day treatment course of remdesivir, a drug that has …
top_10_image_2_2

Top Ten most popular articles on Pharmafile.com this week

June 26, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, top 10

The news this week centres on the pandemic in Europe, with the Independent SAGE group are warning that it is …
shutterstock_2

AstraZeneca continues to ramp up COVID-19 vaccine production with new CMO partnership

June 25, 2020 Manufacturing and Production AstraZeneca, COVID-19, Vaccine

AstraZeneca has continued to build its manufacturing capacity to deliver its COVID-19 vaccine candidate, developed in partnership with the University …
shutterstock_138095450

Boehringer withdraws its £700m investment in Hikma Pharmaceuticals

June 23, 2020 Manufacturing and Production, Sales and Marketing Boehringer, Hikma

Boehringer has revealed that it intends to withdraw its investment from Hikma Pharmaceuticals, with the company poised to sell 28 …
The Gateway to Local Adoption Series

Latest content